Understanding sought

The US Food and Drug Administration said yesterday it had seized from Juul Labs more than a thousand pages of documents related to the company’s sales and marketing practices, according to a story by Ankur Banerjee and Tamara Mathias for Reuters.
The seizures were said to have come during a surprise inspection.
The inspection, completed on Friday, followed a request in April for documents that the FDA believed would help it better understand the high levels of Juul’s appeal and use among young people.
The FDA said it had conducted also inspections of several of Juul’s contract manufacturing units earlier this year.
Meanwhile, Juul Labs CEO Kevin Burns was quoted as saying in a statement that the company had handed over to the FDA since April more than 50,000 pages of documents that supported its public statements, before adding that the meeting with the regulator had been constructive and transparent.
“We want to be part of the solution in preventing underage use, and we believe it will take industry and regulators working together to restrict youth access,” said Burns.